Despite the slightly warmer weather and longer periods of sunshine, we are still in the depths of cold and flu season, a ...

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...

Many nursing home residents are refusing COVID shots this winter, though flu vaccine penetration has remained strong historically.

Respiratory Syncytial Virus (RSV): One of the world's most common childhood respiratory diseases, RSV also affects adults, ...

North Carolina reports a spike in flu cases and 117 deaths, urging the public to get vaccinated and seek early treatment.

After a short reprieve earlier this month, respiratory illness levels have again moved from moderate to high in Illinois, ...

A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.